SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Messina, F; Piaserico, S

Messina, F; Piaserico, S.

Messina F; Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy.
Piaserico S; Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy.

J Eur Acad Dermatol Venereol ; 34(6): e254-e255, 2020 Jun.

Article in English | MEDLINE | ID: covidwho-60370

Subject(s)

Biological Products/administration & dosage; Coronavirus Infections/diagnosis; Immunocompromised Host/immunology; Interleukin-23/antagonists & inhibitors; Pneumonia, Viral/diagnosis; Psoriasis/drug therapy; Severe Acute Respiratory Syndrome/diagnosis; Adult; Arthritis, Psoriatic/diagnosis; Arthritis, Psoriatic/drug therapy; Arthritis, Psoriatic/immunology; Biological Products/adverse effects; COVID-19; COVID-19 Testing; Clinical Laboratory Techniques; Coronavirus Infections/immunology; False Negative Reactions; Female; Follow-Up Studies; Humans; Italy; Pandemics; Pneumonia, Viral/immunology; Psoriasis/diagnosis; Psoriasis/immunology; Risk Assessment; Severe Acute Respiratory Syndrome/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Psoriasis / Biological Products / Immunocompromised Host / Coronavirus Infections / Severe Acute Respiratory Syndrome / Interleukin-23 Type of study: Case report / Cohort study / Diagnostic study / Prognostic study Limits: Adult / Female / Humans Country/Region as subject: Europa Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2020 Document Type: Article Affiliation country: Jdv.16468

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google